Jun 23, 2025
1:30
For every 30 shares held, investors received 1. The price per share adjusted from $0.30 to $0.01.
The split itself did not change the total investment value.
Cellectar Biosciences, Inc. (CLRB) trades on the NASDAQ Capital Market in the Biotechnology industry.
Cellectar Biosciences, Inc. company overviewThe latest split shown was on June 23, 2025. It was a 1-for-30 reverse split, so shareholders received 1 share for every 30 they held.
This history records 6 reverse splits between April 10, 2011 and June 23, 2025.